dc.contributor.author | Eraksoy, Mefküre | |
dc.contributor.author | Baykal, Betül | |
dc.contributor.author | Saruhan Direskeneli, Güher | |
dc.date.accessioned | 2021-03-03T16:30:46Z | |
dc.date.available | 2021-03-03T16:30:46Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Eraksoy M., Saruhan Direskeneli G., Baykal B., "HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey", Human Immunology, cilt.55, sa.1, ss.59-65, 1997 | |
dc.identifier.issn | 0198-8859 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_44a4a829-9119-42a3-925e-87b4d07fb5b0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/49814 | |
dc.identifier.uri | https://avesis.istanbul.edu.tr/api/publication/44a4a829-9119-42a3-925e-87b4d07fb5b0/file | |
dc.identifier.uri | https://doi.org/10.1016/s0198-8859(97) | |
dc.description.abstract | ABSTRACT: The DRB, DQA, and DQB subregions ofthe major histocompatibility complex (MHC) were investigatedby polymerase chain reaction and sequence-specificoligonucleotide probe hybridization (PCR/SSO) in103 multiple sclerosis (MS) patients and 101 healthycontrols from Turkey. Significant differences were detectedbetween MS and control populations in the frequencies ofDRB1*1501 [29 vs. 14, p 5 0.02, odds ratio (OR) 5 2.4],DRB1*04 (35 vs. 18, p 5 0.01, OR 5 2.3), DQB1*0302(30 vs. 15, p 5 0.02, OR 5 2.3), DQB1*0602 (27 vs. 10,p 5 0.005, OR 5 3.2), DQB1*0501 (10 vs. 24, p 5 0.01,OR 5 0.3), DQA1*0101 (16 vs. 31, p 5 0.02, OR 50.4), and DQA1*0103 (7 vs. 19, p 5 0.02, OR 5 0.3).These results confirm the proposed positive association ofthe Dw2 (DRB1*1501 DQA1*0102 DQB1*0602) haplotypewith MS in Caucasians in our Turkish population(25 vs. 8, p 5 0.003, OR 5 3.7). Furthermore, the“putative” haplotype supposed to be more frequent in theMS population of Mediterranean countries, namelyDRB1*04 DQA1*03 DQB1*0302, is also associatedwith MS in Turkey (29 vs. 12, p 5 0.006, OR 5 2.9).The presence of two different haplotypic associations inMS emphasizes the complexity of the genetic susceptibilityto MS in different populations. | |
dc.language.iso | eng | |
dc.subject | Pathophysiology | |
dc.subject | Internal Medicine | |
dc.subject | Assessment and Diagnosis | |
dc.subject | Medicine (miscellaneous) | |
dc.subject | General Medicine | |
dc.subject | Health Sciences | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Family Practice | |
dc.subject | Fundamentals and Skills | |
dc.subject | General Health Professions | |
dc.title | HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey | |
dc.type | Makale | |
dc.relation.journal | Human Immunology | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 55 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 59 | |
dc.identifier.endpage | 65 | |
dc.contributor.firstauthorID | 2522234 | |